enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Antiarthritics - Wikipedia

   en.wikipedia.org/wiki/Antiarthritics

   Gout is another common type of inflammatory arthritis that typically affects one joint at a time. Pharmacological treatment of gout typically relies on the management of flare-ups . Flare-ups are treated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen , steroids , and/or the anti-inflammatory medication colchicine .

3. Your Gout Guide: From Symptoms to Treatment - AOL

   www.aol.com/gout-guide-symptoms-treatment...

   Gout in foot joints is most common, with gout often affecting the big toe joint. However, other joints can be affected as well, particularly those in the lower body. For example, gout in ankles or ...

4. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, Crohn's disease, ulcerative colitis Intetumumab [83] [84] mab: human: CD51: solid tumors (prostate cancer, melanoma) Inolimomab: mab: mouse: CD25 (α chain of IL-2 receptor) graft versus host disease: Inotuzumab ozogamicin [39] Besponsa: mab: humanized: CD22: Y: Acute ...

5. Rheumatology - Wikipedia

   en.wikipedia.org/wiki/Rheumatology

   The biologic agent rituximab (anti-B cell therapy) is now licensed for use in refractory rheumatoid arthritis. [9] Physiotherapy is vital in the treatment of many rheumatological disorders. Occupational therapy can help patients find alternative ways for common movements that would otherwise be restricted by their disease.

6. Managing Out-of-Control Chronic Gout: Going Beyond Oral ...

   www.aol.com/lifestyle/managing-control-chronic...

   The post Managing Out-of-Control Chronic Gout: Going Beyond Oral Treatments appeared first on Reader's Digest. Skip to main content. 24/7 Help. For premium support please call: 800 ...

7. Adalimumab - Wikipedia

   en.wikipedia.org/wiki/Adalimumab

   Adalimumab, sold under the brand name Humira and others, is a disease-modifying antirheumatic drug and monoclonal antibody used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis.